Organised by VISION-DMD and the EURO-NMD ERN, this workshop will look at how biomarkers and imaging are used in clinical studies for DMD and other neuromuscular diseases. Experts will review current challenges in validation and use. This workshop will be the first step in developing a roadmap for future use of innovative endpoints. The key audience is ERN clinicians, academics, patient groups, industry and regulators.